MannKind Corp. Company Profile (NASDAQ:MNKD)

About MannKind Corp.

MannKind Corp. logoMannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: MNKD
  • CUSIP: 56400P20
Key Metrics:
  • Previous Close: $0.64
  • 50 Day Moving Average: $0.6558
  • 200 Day Moving Average: $0.7226
  • 52-Week Range: $0.41 - $2.24
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.09
  • P/E Growth: 0.2000
  • Market Cap: $305.25M
  • Outstanding Shares: 478,376,000
  • Beta: 3.23
  • Return on Equity: -15.95%
  • Return on Assets: 46.57%
  • Debt-to-Equity Ratio: -0.62%
  • Current Ratio: 0.46%
  • Quick Ratio: 0.41%
Additional Links:
Companies Related to MannKind Corp.:

Analyst Ratings

Consensus Ratings for MannKind Corp. (NASDAQ:MNKD) (?)
Ratings Breakdown: 4 Sell Ratings, 1 Hold Rating
Consensus Rating:Sell (Score: 1.20)
Consensus Price Target: $0.32 (50.37% downside)

Analysts' Ratings History for MannKind Corp. (NASDAQ:MNKD)
DateFirmActionRatingPrice TargetDetails
11/11/2016JPMorgan Chase & Co.Reiterated RatingUnderweightView Rating Details
8/31/2016S&P Equity ResearchLower Price Target$0.84 -> $0.70View Rating Details
8/21/2016Piper Jaffray Cos.Set Price TargetSell$0.10View Rating Details
6/1/2016Royal Bank Of CanadaLower Price TargetUnderperform$1.00 -> $0.15View Rating Details
4/28/2016JMP SecuritiesReiterated RatingHoldView Rating Details
4/1/2016Goldman Sachs Group Inc.Reiterated RatingSellView Rating Details
1/6/2016Griffin SecuritiesUpgradeNeutral -> Buy$4.00View Rating Details
11/14/2015Jefferies GroupReiterated RatingBuy$9.00View Rating Details
5/11/2015MLV & Co.Lower Price TargetHold$7.00 -> $4.00View Rating Details
(Data available from 1/21/2015 forward)


Earnings History for MannKind Corp. (NASDAQ:MNKD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016Q3 2016($0.05)$0.26$2.00 million$162.35 millionViewListenView Earnings Details
8/8/2016Q2($0.06)($0.07)$0.03 millionViewN/AView Earnings Details
5/9/2016Q116($0.04)($0.06)ViewN/AView Earnings Details
3/14/2016Q4($0.05)($0.66)$0.35 millionViewN/AView Earnings Details
11/9/2015Q315($0.07)($0.08)ViewN/AView Earnings Details
8/10/2015Q215($0.08)($0.07)$0.53 millionViewListenView Earnings Details
5/7/2015Q115($0.08)($0.08)ViewListenView Earnings Details
2/24/2015Q414($0.09)($0.09)$3.13 millionViewListenView Earnings Details
11/3/2014Q314$0.04($0.09)$66.60 millionViewListenView Earnings Details
8/11/2014Q214($0.12)($0.19)ViewListenView Earnings Details
5/12/2014Q114($0.13)($0.14)ViewListenView Earnings Details
2/18/2014Q4($0.14)($0.16)$0.43 millionViewListenView Earnings Details
11/4/2013Q313($0.14)($0.17)ViewListenView Earnings Details
8/9/2013Q2 2013($0.14)($0.16)ViewN/AView Earnings Details
5/9/2013Q1 2013($0.15)($0.15)ViewListenView Earnings Details
2/11/2013Q4 2012($0.19)($0.23)ViewListenView Earnings Details
11/1/2012Q312($0.24)($0.22)ViewN/AView Earnings Details
8/7/2012($0.24)($0.23)ViewN/AView Earnings Details
5/9/2012($0.23)($0.27)ViewN/AView Earnings Details
2/22/2012($0.32)($0.30)ViewN/AView Earnings Details
11/3/2011($0.32)($0.31)ViewN/AView Earnings Details
8/4/2011($0.30)($0.37)ViewN/AView Earnings Details
5/9/2011($0.29)($0.34)ViewN/AView Earnings Details
2/10/2011($0.40)($0.33)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for MannKind Corp. (NASDAQ:MNKD)
Current Year EPS Consensus Estimate: $0.12 EPS
Next Year EPS Consensus Estimate: $-0.09 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.03)($0.03)($0.03)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.03)($0.03)($0.03)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)


Dividend History for MannKind Corp. (NASDAQ:MNKD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for MannKind Corp. (NASDAQ:MNKD)
Insider Ownership Percentage: 0.94%
Institutional Ownership Percentage: 20.04%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/3/2017Matthew J PfefferCEOBuy4,540$0.54$2,451.60View SEC Filing  
1/3/2017Rosabel Realica AlinayaSVPBuy9,043$0.54$4,883.22View SEC Filing  
8/26/2016Michael CastagnaInsiderBuy17,500$0.78$13,650.00View SEC Filing  
8/24/2016Michael CastagnaInsiderBuy15,000$0.87$13,050.00View SEC Filing  
8/23/2016Michael CastagnaInsiderBuy25,000$0.94$23,500.00View SEC Filing  
8/15/2016Matthew J PfefferCEOBuy25,000$0.99$24,750.00View SEC Filing  
8/12/2016Michael CastagnaInsiderBuy25,000$1.00$25,000.00View SEC Filing  
5/17/2016Michael CastagnaInsiderBuy50,000$0.93$46,500.00View SEC Filing  
4/24/2015Hakan EdstromCEOSell73,460$4.83$354,811.80View SEC Filing  
3/27/2015Hakan EdstromCEOSell73,460$5.21$382,726.60View SEC Filing  
2/10/2015Hakan EdstromCEOSell73,460$7.75$569,315.00View SEC Filing  
2/5/2015David ThomsonVPSell80,000$7.00$560,000.00View SEC Filing  
1/5/2015Diane PalumboVPSell188,999$5.95$1,124,544.05View SEC Filing  
11/24/2014David ThomsonVPSell118,114$6.14$725,219.96View SEC Filing  
10/3/2014Juergen MartensVPSell63,800$5.48$349,624.00View SEC Filing  
8/27/2014Juergen MartensVPSell417$7.60$3,169.20View SEC Filing  
8/7/2014David ThomsonVPSell30,000$8.16$244,800.00View SEC Filing  
7/21/2014Juergen MartensVPSell26,458$9.65$255,319.70View SEC Filing  
7/15/2014Diane PalumboVPSell17,901$10.01$179,189.01View SEC Filing  
7/1/2014Matthew J PfefferCFOSell20,000$10.44$208,800.00View SEC Filing  
6/30/2014Hakan EdstromCOOBuy1,692$4.42$7,478.64View SEC Filing  
6/27/2014Juergen MartensVPSell25,417$10.53$267,641.01View SEC Filing  
6/26/2014David ThomsonVPSell30,000$10.51$315,300.00View SEC Filing  
6/20/2014Juergen MartensVPSell1,458$10.34$15,075.72View SEC Filing  
6/16/2014Diane PalumboVPSell17,902$10.59$189,582.18View SEC Filing  
6/5/2014Juergen MartensVPSell120,000$11.00$1,320,000.00View SEC Filing  
6/4/2014David ThomsonVPSell133,000$9.95$1,323,350.00View SEC Filing  
6/3/2014Diane PalumboVPSell52,957$9.50$503,091.50View SEC Filing  
5/23/2014Juergen MartensVPSell25,000$7.65$191,250.00View SEC Filing  
5/19/2014Juergen MartensVPSell76,899$7.50$576,742.50View SEC Filing  
5/15/2014Diane PalumboVPSell18,176$7.06$128,322.56View SEC Filing  
1/24/2014Juergen MartensVPSell50,000$5.56$278,000.00View SEC Filing  
12/31/2013Hakan EdstromCOOBuy1,589$4.53$7,198.17View SEC Filing  
12/20/2013Juergen MartensVPSell32,054$5.00$160,270.00View SEC Filing  
12/11/2013David ThomsonVPSell150,000$5.00$750,000.00View SEC Filing  
11/29/2013Juergen MartensVPSell48,057$5.01$240,765.57View SEC Filing  
11/15/2013Diane PalumboVPSell25,000$5.02$125,500.00View SEC Filing  
8/28/2013David ThomsonVPSell19,204$5.78$110,999.12View SEC Filing  
8/26/2013Juergen MartensVPSell20,000$5.52$110,400.00View SEC Filing  
8/1/2013Matthew J PfefferCFOSell10,000$8.00$80,000.00View SEC Filing  
7/2/2013Matthew J PfefferCFOSell10,000$7.00$70,000.00View SEC Filing  
6/30/2013Diane PalumboVPBuy1,610$1.96$3,155.60View SEC Filing  
6/30/2013Matthew J PfefferCFOBuy7,448$1.96$14,598.08View SEC Filing  
6/3/2013Diane PalumboVPSell66,849$7.50$501,367.50View SEC Filing  
5/16/2013Diane PalumboVPSell26,829$5.25$140,852.25View SEC Filing  
5/15/2013Matthew J PfefferCFOSell10,000$5.00$50,000.00View SEC Filing  
12/31/2012Matthew J PfefferCFOBuy1,056$1.95$2,059.20View SEC Filing  
12/21/2012Alfred E MannMajor ShareholderBuy40,000,000$2.59$103,600,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for MannKind Corp. (NASDAQ:MNKD)
News IconDevling Into Shares of MannKind Corporation (NASDAQ:MNKD), What Are Analysts Predicting for 2017? - Wall Street Beacon (NASDAQ:MNKD) - January 19 at 8:49 PM
News IconSLM Corporation (NASDAQ:SLM) has current Price to Earning Ratio of 19.69 (NASDAQ:MNKD) - January 18 at 7:09 PM
News IconMannKind sells Valencia building for $17.3M (NASDAQ:MNKD) - January 18 at 7:09 PM logoMannKind Has a New Plan, but Will It Work? (NASDAQ:MNKD) - January 18 at 7:09 PM
News IconMannKind Corp. (NASDAQ:MNKD) has Current Market Capitalizaion of $309.23 Million (NASDAQ:MNKD) - January 17 at 11:56 PM
News IconInvestors Swarm in on MannKind Corporation (NASDAQ:MNKD) - Prospect Journal (NASDAQ:MNKD) - January 17 at 6:55 PM
News IconMannKind ‘aggressively’ moving forward with inhalable epinephrine (NASDAQ:MNKD) - January 16 at 7:08 PM
News IconStock ABR MannKind Corporation (NASDAQ:MNKD) At 5 - Stock Observer (NASDAQ:MNKD) - January 16 at 5:28 AM
News IconMarkets End Mostly Higher, How Did This Stock Fare: MannKind Corporation (NASDAQ:MNKD) - Wall Street Beacon (NASDAQ:MNKD) - January 14 at 11:41 PM logoMannKind (MNKD) Presents At 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:MNKD) - January 13 at 7:53 PM logoEntry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:MNKD) - January 13 at 12:10 AM logoForm 8-K MANNKIND CORP For: Jan 06 (NASDAQ:MNKD) - January 13 at 12:10 AM logoMANNKIND CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:MNKD) - January 13 at 12:10 AM
News IconMannKind Corporation (NASDAQ:MNKD) declared EPS of 0.26 - The Newburgh Press (NASDAQ:MNKD) - January 12 at 7:09 PM
News IconWall Street and Armchair Analysts Weigh in on MannKind Corporation (NASDAQ:MNKD) Heading Into The New Year - Wall Street Beacon (NASDAQ:MNKD) - January 12 at 7:09 PM logoMannKind Corporation (NASDAQ:MNKD) Files An 8-K Other Events - Market Exclusive (NASDAQ:MNKD) - January 11 at 7:12 PM
News IconMannKind Corp. (NASDAQ:MNKD) shows monthly volitility of 10.47% - The Newburgh Press (NASDAQ:MNKD) - January 11 at 7:12 PM
News IconPlacing the Bulls-Eye Focus on MannKind Corporation (NASDAQ:MNKD) - Prospect Journal (NASDAQ:MNKD) - January 10 at 7:28 PM logoMANNKIND CORP Files SEC form 8-K, Other Events (NASDAQ:MNKD) - January 10 at 7:28 PM
News IconIs MannKind Corp. Ready to Rebound in 2017? - Fox Business (NASDAQ:MNKD) - January 10 at 12:21 AM
News Advances in Biotechnology Sector (NASDAQ:MNKD) - January 9 at 7:19 PM logoMannKind Receives $30.6 Million From Sanofi (NASDAQ:MNKD) - January 9 at 7:19 PM logoIs MannKind Corp. Ready to Rebound in 2017? (NASDAQ:MNKD) - January 9 at 12:27 PM
News IconStock ABR Of MannKind Corporation (NASDAQ:MNKD) At 5 - Stock Observer (NASDAQ:MNKD) - January 8 at 11:20 PM logoStock Update (NASDAQ:MNKD): MannKind Corporation Announces Key Addition to Its Executive Management Ranks - Smarter Analyst (NASDAQ:MNKD) - January 7 at 12:21 AM
News IconMannKind Adds Execs, Receives Payment (NASDAQ:MNKD) - January 6 at 7:18 PM logoCORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference - GlobeNewswire (press release) (NASDAQ:MNKD) - January 5 at 8:00 PM logoMannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference (NASDAQ:MNKD) - January 5 at 8:00 PM logoCORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference (NASDAQ:MNKD) - January 5 at 8:00 PM logoForm 4 MANNKIND CORP For: Jan 03 Filed by: PFEFFER MATTHEW J (NASDAQ:MNKD) - January 4 at 4:42 PM
News IconSVP, Prin Acctg Officer of MannKind Corporation (NASDAQ:MNKD), Alinaya Rosabel Realica, buys 9,043 shares worth $4,883 (NASDAQ:MNKD) - January 4 at 4:42 PM
News IconMannKind Corporation Receives $1 Million Milestone From RLS (NASDAQ:MNKD) - January 4 at 4:42 PM logoStock Update (NASDAQ:MNKD): MannKind Corporation Announces Key Addition to Its Executive Management Ranks (NASDAQ:MNKD) - January 4 at 4:42 PM logoMannKind Announces Key Addition to Its Executive Management Ranks (NASDAQ:MNKD) - January 4 at 4:42 PM logoMannKind's $1M Milestone: Good News, But Barely - Seeking Alpha (NASDAQ:MNKD) - January 4 at 6:56 AM
News IconMannKind Receives $1 Million Milestone Payment (NASDAQ:MNKD) - January 3 at 10:33 PM logoMannKind (MNKD) Receives $1M Milestone Payment from Receptor Life Sciences (NASDAQ:MNKD) - January 3 at 10:33 PM logoCompany Update (NASDAQ:MNKD): MannKind Corporation Receives $1 Million Milestone From RLS (NASDAQ:MNKD) - January 3 at 10:33 PM logoThree new year's resolutions Google needs to keep in 2017 (NASDAQ:MNKD) - January 3 at 10:51 AM logoJounce Therapeutics Files for $75M IPO before New Year’s Eve (NASDAQ:MNKD) - January 3 at 10:51 AM logoMannKind Receives $1 Million Milestone From RLS (NASDAQ:MNKD) - January 3 at 10:51 AM logoMannkind's Affrezza Is Fizzling Out - Seeking Alpha (NASDAQ:MNKD) - December 31 at 9:15 AM
News IconAnalyst Price Objective in View for Walt Disney Co (NYSE:DIS) (NASDAQ:MNKD) - December 30 at 6:57 PM logoMannKind (MNKD) Shares March Higher, Can It Continue? (NASDAQ:MNKD) - December 29 at 9:46 AM
News IconBiotechs Looking into the Heart of the Problem (NASDAQ:MNKD) - December 28 at 6:29 PM logoBiotech Short Interest Sinks (NASDAQ:MNKD) - December 28 at 10:18 AM logoNate Pile's Top Recommendations For 2017 (NASDAQ:MNKD) - December 27 at 6:29 PM
News IconStocks in the News: MannKind Corp. (NASDAQ:MNKD), Xerox Corporation (NYSE:XRX) - The Newburgh Press (NASDAQ:MNKD) - December 23 at 4:56 AM logo[video]2016 Was a Terrible Year for Biotech but the Tweets Were on Point (NASDAQ:MNKD) - December 22 at 6:54 PM
News IconMannKind Corporation (NASDAQ:MNKD) reported Beta of 3.25 (NASDAQ:MNKD) - December 21 at 7:27 PM


MannKind Corp. (NASDAQ:MNKD) Chart for Saturday, January, 21, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for MannKind Corp. (NASDAQ:MNKD)

Earnings History Chart

Earnings by Quarter for MannKind Corp. (NASDAQ:MNKD)

Dividend History Chart

Dividend Payments by Quarter for MannKind Corp. (NASDAQ:MNKD)

Last Updated on 1/21/2017 by Staff